{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:10:15Z","timestamp":1789013415342,"version":"build-2803163510"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T00:00:00Z","timestamp":1511913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"keryx"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188712","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T13:28:33Z","timestamp":1511962113000},"page":"e0188712","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-0534","authenticated-orcid":true,"given":"Glenn M.","family":"Chertow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Neylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo E.","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"key":"ref1","unstructured":"United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016."},{"issue":"9731","key":"ref2","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"K Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"ref3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"AS Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3346\/jkms.2017.32.2.257","article-title":"Nutritional status in adults with predialysis chronic kidney disease: KNOW-CKD study","volume":"32","author":"YY Hyun","year":"2017","journal-title":"J Korean Med Sci"},{"issue":"4","key":"ref5","first-page":"280","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.00720116","article-title":"Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function","volume":"11","author":"KL Naylor","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-10-71","article-title":"Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment","volume":"10","author":"AA Pagels","year":"2012","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004","volume":"4","author":"S Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"ref9","first-page":"161","article-title":"Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron","volume":"19","author":"L Gotloib","year":"2006","journal-title":"J Nephrol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2215\/CJN.04280609","article-title":"Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease?","volume":"5","author":"S Stancu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","article-title":"Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers","year":"2001"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease","volume":"28","author":"RN Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis","volume":"16","author":"A Levin","year":"2003","journal-title":"Semin Dial"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-nutr-071812-161205","article-title":"Iron nutrition and premenopausal women: effects of poor iron status on physical and neuropsychological performance","volume":"33","author":"JP McClung","year":"2013","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"ref15","first-page":"363","article-title":"Iron deficiency is a determinant of functional capacity and health-related quality of life 30 days after an acute coronary syndrome","volume":"70","author":"O Mero\u00f1o","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2215\/CJN.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"CS Ritter","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","unstructured":"Auryxia (ferric citrate) tablets: US prescribing information. Boston, MA: Keryx Biopharmaceuticals; 2016."},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1681\/ASN.2014020212","article-title":"Ferric citrate controls phosphorus and delivers iron in patients on dialysis","volume":"26","author":"JB Lewis","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2014.10.014","article-title":"A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD stages 3\u20135","volume":"65","author":"GA Block","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1681\/ASN.2016101053","article-title":"Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia","volume":"28","author":"S Fishbane","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"R Agarwal","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.24201","article-title":"How we diagnose and treat iron deficiency anemia","volume":"91","author":"M Auerbach","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0272-6386(95)90105-1","article-title":"Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin","volume":"25","author":"RL Wingard","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"IC Macdougall","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"WY Qunibi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ndt\/gfv293","article-title":"A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia","volume":"31","author":"PA Kalra","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000096174","article-title":"A randomized controlled trial of oral versus intravenous iron in chronic kidney disease","volume":"26","author":"R Agarwal","year":"2006","journal-title":"Am J Nephrol"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD","volume":"68","author":"DB Van Wyck","year":"2005","journal-title":"Kidney Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"GA Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1172\/JCI81928","article-title":"CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders","volume":"126","author":"X Bai","year":"2016","journal-title":"J Clin Invest"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"O Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"M Wolf","year":"2012","journal-title":"Kidney Int"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"C Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"23","key":"ref34","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"T Isakova","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"JH Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"J Munoz Mendoza","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2\u20134","volume":"9","author":"S Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12185-011-0878-8","article-title":"Establishment of a simple test for iron absorption from the gastrointestinal tract","volume":"93","author":"M Kobune","year":"2011","journal-title":"Int J Hematol"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2215\/CJN.05170513","article-title":"Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD","volume":"9","author":"K Yokoyama","year":"2014","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:34:50Z","timestamp":1540254890000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188712"}},"subtitle":[],"editor":[{"given":"Rosa Maria Affonso","family":"Moys\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,29]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188712","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,29]]}}}